These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2508748)

  • 1. Comparison of recombinant tissue-type plasminogen activator (rt-PA) expressed in mouse C127 cells and human vascular plasminogen activator (HV-PA).
    Hamaguchi M; Takahashi I; Takehara T; Takamatsu J; Saito H
    Biochim Biophys Acta; 1989 Nov; 1009(2):143-50. PubMed ID: 2508748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biochemical and biologic properties of rt-PA del (K296-G302), a recombinant human tissue-type plasminogen activator deletion mutant resistant to plasminogen activator inhibitor-1.
    Li XK; Lijnen HR; Nelles L; Van Hoef B; Stassen JM; Collen D
    Blood; 1992 Jan; 79(2):417-29. PubMed ID: 1730087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of a recombinant fusion protein of the finger domain of tissue-type plasminogen activator with a truncated single chain urokinase-type plasminogen activator.
    Gheysen D; Lijnen HR; Piérard L; de Foresta F; Demarsin E; Jacobs P; De Wilde M; Bollen A; Collen D
    J Biol Chem; 1987 Aug; 262(24):11779-84. PubMed ID: 3114253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-glycosylation and in vitro enzymatic activity of human recombinant tissue plasminogen activator expressed in Chinese hamster ovary cells and a murine cell line.
    Parekh RB; Dwek RA; Rudd PM; Thomas JR; Rademacher TW; Warren T; Wun TC; Hebert B; Reitz B; Palmier M
    Biochemistry; 1989 Sep; 28(19):7670-9. PubMed ID: 2514793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Construction and expression of hybrid plasminogen activators prepared from tissue-type plasminogen activator and urokinase-type plasminogen activator genes.
    Lee SG; Kalyan N; Wilhelm J; Hum WT; Rappaport R; Cheng SM; Dheer S; Urbano C; Hartzell RW; Ronchetti-Blume M
    J Biol Chem; 1988 Feb; 263(6):2917-24. PubMed ID: 3125172
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of domain deletion and/or duplication mutants of a recombinant chimera of tissue-type plasminogen activator and urokinase-type plasminogen activator (rt-PA/u-PA).
    Nelles L; Lijnen HR; Van Nuffelen A; Demarsin E; Collen D
    Thromb Haemost; 1990 Aug; 64(1):53-60. PubMed ID: 2148847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.
    Rijken DC; Collen D
    J Biol Chem; 1981 Jul; 256(13):7035-41. PubMed ID: 6787058
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative thrombolytic properties of tissue-type plasminogen activator and of a plasminogen activator inhibitor-1-resistant glycosylation variant, in a combined arterial and venous thrombosis model in the dog.
    Collen D; Stassen JM; Yasuda T; Refino C; Paoni N; Keyt B; Roskams T; Guerrero JL; Lijnen HR; Gold HK
    Thromb Haemost; 1994 Jul; 72(1):98-104. PubMed ID: 7974384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of a modified human tissue plasminogen activator comprising a kringle-2 and a protease domain.
    Burck PJ; Berg DH; Warrick MW; Berg DT; Walls JD; Jaskunas SR; Crisel RM; Weigel B; Vlahos CJ; McClure DB
    J Biol Chem; 1990 Mar; 265(9):5170-7. PubMed ID: 2108167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. On the molecular interactions between fibrin, tissue-type plasminogen activator and plasminogen.
    Lijnen HR; Van Hoef B; Collen D
    Thromb Res Suppl; 1990; 10():45-54. PubMed ID: 2107598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Biological properties of hybrid plasminogen activators.
    Hung PP; Wilhelm J; Kalyan NK; Cheng SM; James HL; Nachowiak D; Weinheimer CJ; Sobel BE; Bergmann SR; Lee SG
    Adv Exp Med Biol; 1990; 281():201-8. PubMed ID: 2129369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical, thrombolytic and pharmacokinetic properties of rt-PA P47G, K49N, a substitution variant of human tissue-type plasminogen activator.
    Nelles L; Li XK; Vanlinthout I; De Cock F; Lijnen HR; Collen D
    Thromb Haemost; 1992 Apr; 67(4):445-52. PubMed ID: 1631793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transgenic expression of a variant of human tissue-type plasminogen activator in goat milk: purification and characterization of the recombinant enzyme.
    Denman J; Hayes M; O'Day C; Edmunds T; Bartlett C; Hirani S; Ebert KM; Gordon K; McPherson JM
    Biotechnology (N Y); 1991 Sep; 9(9):839-43. PubMed ID: 1367545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stimulation by fibrinogen of the amidolytic activity of single-chain tissue plasminogen activator.
    Urano T; deSerrano VS; Urano S; Castellino FJ
    Arch Biochem Biophys; 1989 Apr; 270(1):356-62. PubMed ID: 2494944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and biological properties of a recombinant tissue-type plasminogen activator derived from the rat JMI-229 cell line.
    Lijnen HR; Webb PD; Van Hoef B; De Cock F; Stassen JM; Prior SD; Collen D
    Thromb Haemost; 1992 Feb; 67(2):239-47. PubMed ID: 1621244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effector roles of kringle 1 and kringle 2 in the enzymatic properties of recombinant tissue-type plasminogen activator as revealed by generation of recombinant molecules containing each kringle linked to the protease domain.
    Rydzewski A; Castellino FJ
    Arch Biochem Biophys; 1993 Jan; 300(1):472-82. PubMed ID: 8424682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo distribution of Tc-99m labeled recombinant tissue-type plasminogen activator in control and thrombus-bearing rats.
    Tsukamoto E
    Ann Nucl Med; 1992 Aug; 6(3):177-84. PubMed ID: 1389893
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clot penetration and retention by plasminogen activators promote fibrinolysis.
    Marcos-Contreras OA; Ganguly K; Yamamoto A; Shlansky-Goldberg R; Cines DB; Muzykantov VR; Murciano JC
    Biochem Pharmacol; 2013 Jan; 85(2):216-22. PubMed ID: 23098998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recombinant variants of tissue-type plasminogen activator containing amino acid substitutions in the finger domain.
    Yahara H; Matsumoto K; Maruyama H; Nagaoka T; Ikenaka Y; Yajima K; Fukao H; Ueshima S; Matsuo O
    Thromb Haemost; 1992 Dec; 68(6):672-7. PubMed ID: 1287881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of retraction on the lysis of human clots with fibrin specific and non-fibrin specific plasminogen activators.
    Sabovic M; Lijnen HR; Keber D; Collen D
    Thromb Haemost; 1989 Dec; 62(4):1083-7. PubMed ID: 2515603
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.